CN
| ID | Title |
| 8528 | Dynamic ctDNA to inform the precise management of resected NSCLC: LUNGCA-2 study |
| 9041 | Pre-treatment plasma-informed circulating tumor DNA detection as an early identification of therapeutic benefit for patients with untreated advanced lung squamous cell carcinoma |
| 10521 | Real-world performance of a multi-cancer early detection test based on integrative analysis of cell-free DNA whole-methylome sequencing |
| e21003 | Tumor immune microenvironment in BRAF V600E mutant lung adenocarcinoma |
| e20590 | Correlation analysis of MRD positivity after non-small cell lung cancer surgery |
| e14617 | Atezolizumab plus bevacizumab combined with transarterial embolization plus hepatic arterial infusion -chemotherapy for unresectable hepatocellular carcinoma with a diameter larger than 8 cm: a retrospective study |
| e16141 | Identification of prognostic tumor microenvironment in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy in combination with lenvatinib and PD-1 inhibitors |
#02-01/02, The Kendall, 50 Science Park Road. Singapore Science Park 2, Singapore 117406
Tel: +65 6047 0252 ; Email: info@genecast.com.sg
Copyright © 2014-2026 Genecast Group Inc. | Privacy Policy
